After Hours Most Active for Jul 25, 2025 : GRAB, TRI, IBRX, VZ, PFE, PCG, T, INTC, NVDA, INDV, CRH, MAGN

The NASDAQ 100 After Hours Indicator registered a modest gain to 23,287.1, accompanied by robust trading volume exceeding 112 million shares. Notable individual stock activity included Verizon and PG&E receiving multiple upward earnings forecast revisions, with PG&E anticipating a 31% EPS increase for its upcoming report. Thomson Reuters traded above its target price, while ImmunityBio exhibited high days to cover. Several other active stocks, including NVIDIA and CRH, maintained 'buy' recommendations from analysts.

Analysis

The NASDAQ 100 After Hours Indicator registered a marginal gain to 23,287.1 on a high volume of over 112 million shares, suggesting a constructive but measured post-market sentiment. Forward-looking indicators present a positive outlook for several companies, most notably PG&E Corp (PCG) and Indivior PLC (INDV). PCG has seen three upward earnings forecast revisions for its Dec 2025 quarter and is expected to report a 31% year-over-year EPS increase for its upcoming June quarter. Similarly, INDV is projected to report a 44% YoY EPS increase. Verizon (VZ) also shows strengthening fundamentals with three recent upward earnings revisions. In contrast, valuation metrics offer mixed signals; Thomson Reuters (TRI) is trading 2.01% above its consensus target price, implying it may be fully valued, while Pfizer (PFE), Verizon (VZ), and Magnera Corporation (MAGN) are trading at 88.54%, 89.75%, and 76.8% of their respective targets, suggesting potential upside. A notable special situation is ImmunityBio, Inc. (IBRX), which has a high days to cover ratio of 12.54, indicating significant short interest that could lead to heightened volatility.

Key Decisions for Investors

• Investors should monitor PG&E Corp and Indivior PLC ahead of their July 31, 2025 earnings reports, as consensus forecasts for 31% and 44% year-over-year EPS growth, respectively, could serve as significant catalysts.
• Consider the positive fundamental momentum for Verizon and PG&E, both of which have received three upward earnings forecast revisions in the last four weeks, signaling an improving analyst outlook.
• Be aware of the high short interest in ImmunityBio, where a days-to-cover figure of 12.54 suggests a potential for significant price volatility or a short squeeze.
• Evaluate valuation discrepancies, noting that Thomson Reuters is trading above its consensus price target, which may limit further upside, while Magnera Corp's position at 76.8% of its target price suggests substantial room for appreciation if analyst targets are realized.